New study aims to spot heart trouble early in septic newborns

NCT ID NCT07572916

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will examine heart function in 80 newborns with sepsis using a special ultrasound (tissue Doppler echocardiography) and blood tests for cardiac troponin and other sepsis markers. The goal is to see if these tests can predict heart problems early. The study includes both preterm and term infants with confirmed sepsis, compared to healthy newborns.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors detect heart problems early in newborns with sepsis, potentially improving care and outcomes.

What could go wrong

This is an observational study, not a treatment trial. It is small (80 participants) and not yet recruiting, so results may not apply broadly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS, MARKERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neonatal sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Faculty of Medicine

    Asyut, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••